WHO ICTRP trial
Ginkgo biloba combined with prednisone acetate tablets for the treatment of…
ChiCTR2500108098 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2500108098 |
|---|---|
| Public title | Ginkgo biloba combined with prednisone acetate tablets for the treatment of tinnitus after cochlear implantation: A randomized controlled trial |
| Scientific title | Ginkgo biloba combined with prednisone acetate tablets for the treatment of tinnitus after cochlear implantation: A randomized controlled trial |
| Primary sponsor | Shandong Second Provincial General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Tinnitus after cochlear implant surgery |
| Interventions | Experimental group:Ginkgo bilobaand Prednisone Acetate Tablets;Positive control group:Prednisone Acetate Tablets;Blank group:None |
| Registration date | Aug 25, 2025 |
| Target size | Experimental group:44;Positive control group:44;Blank group:44 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: